TABLE 1.
Virus strain | Abbreviation | Clinical outcome of patient | HA clade | Receptor-binding specificityb |
PB1-F2 | PB2 |
NS1 |
||||
---|---|---|---|---|---|---|---|---|---|---|---|
α2,3 | α2,6 | 66 | 591 | 627 | 701 | 92 | C terminus | ||||
A/Vietnam/UT3028II/2004 clone3 | VN3028IIcl3 | Died | 1 | ++++ | ++++ | N | Q | K | D | D | ESEV |
A/Vietnam/UT30259/2004 | VN30259 | Died | 1 | ++++ | ++ | N | Q | K | D | D | ESEV |
A/Vietnam/UT3040/2004 | VN3040 | Died | 1 | ++++ | – | N | Q | K | D | D | 10-aa deletion |
A/Vietnam/UT3062/2004 | VN3062 | Died | 1 | ++++ | – | N | Q | K | D | D | ESEV |
A/Vietnam/30408/2005 clone7 | VN30408cl7 | Recovered | 1 | ++++ | +++ | N | Q | K | D | D | ESEV |
A/Vietnam/UT30850/2005 | VN30850 | Died | 2.3.4 | ++++ | – | N | Q | K | D | D | ESEV |
For PB1-F2, PB2, and NS1, the amino acid at the position(s) indicated in the subheadings is specified.
The level of receptor-binding affinity is indicated using a “+/−” scale, where “−” indicates no receptor binding affinity, “+” indicates affinity, and the number of “+” symbols indicates the intensity of the receptor-binding affinity (21).